Cargando…

Efficacy and Safety of Intragastric Balloon Therapy Compared to a Multidisciplinary Weight Loss Program (OPTIFAST) in a Real-World Population: A Propensity Score Matching Analysis

INTRODUCTION: Obesity is a major global health problem associated with comorbidities such as diabetes, cardiovascular disease, and cancer. Bariatric surgery is recognized to be the most effective weight loss intervention, but it is highly invasive and costly and can have serious side effects. Intrag...

Descripción completa

Detalles Bibliográficos
Autores principales: Oster, Miriam, Hein, Nathalena, Aksan, Aysegül, Krammer, Heiner, Theodoridou, Sophia, Stein, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889727/
https://www.ncbi.nlm.nih.gov/pubmed/36257288
http://dx.doi.org/10.1159/000524895
_version_ 1784880795512471552
author Oster, Miriam
Hein, Nathalena
Aksan, Aysegül
Krammer, Heiner
Theodoridou, Sophia
Stein, Jürgen
author_facet Oster, Miriam
Hein, Nathalena
Aksan, Aysegül
Krammer, Heiner
Theodoridou, Sophia
Stein, Jürgen
author_sort Oster, Miriam
collection PubMed
description INTRODUCTION: Obesity is a major global health problem associated with comorbidities such as diabetes, cardiovascular disease, and cancer. Bariatric surgery is recognized to be the most effective weight loss intervention, but it is highly invasive and costly and can have serious side effects. Intragastric balloon (IGB) placement by endoscopy and hypocaloric diets are among a number of techniques that have been used in patients unsuitable for, or unwilling to undergo, obesity surgery. In this study, we compared the efficacy, safety, and cost-effectiveness of the hypocaloric OPTIFAST program (OPT) with endoscopic IGB placement for weight loss. METHODS: In this retrospective observational cohort propensity score-weighted comparison (performed May 2014 to December 2020), participants with a BMI of 30–55 kg/m<sup>2</sup>, aged 18–70 years, were randomized to OPT or IGB for 26 weeks, followed by a weight maintenance phase. Patients were matched according to age, gender, and BMI. The study outcomes were percentage excess body weight lost, total body weight lost (TBWL), and percentage TBWL (%TBWL). RESULTS: A total of 148 participants (75% of those randomized; 74 OPT, 74 IGB) made up the ITT population. Mean age was 44.1 ± 10.4 years, and the patients were predominantly female (77%). Baseline BMI was 44.1 ± 10.4 kg/m<sup>2</sup>. At 26 weeks, %TBWL in the OPT group was 19.6 ± 6.8% versus 11.9 ± 6.7% for IGB (p < 0.001). At 52 weeks, %TBWL for OPT was 18.2 ± 9.0% versus 12.0 ± 6.6% for IGB (p < 0.001). The OPT cohort also experienced significantly fewer adverse events compared with the IGB group. CONCLUSION: IGB placement and OPT induce clinically meaningful weight loss. However, OPT appears to induce clinically superior weight loss and has economic advantages through lower rates of complications and adverse events.
format Online
Article
Text
id pubmed-9889727
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-98897272023-02-02 Efficacy and Safety of Intragastric Balloon Therapy Compared to a Multidisciplinary Weight Loss Program (OPTIFAST) in a Real-World Population: A Propensity Score Matching Analysis Oster, Miriam Hein, Nathalena Aksan, Aysegül Krammer, Heiner Theodoridou, Sophia Stein, Jürgen Obes Facts Research Article INTRODUCTION: Obesity is a major global health problem associated with comorbidities such as diabetes, cardiovascular disease, and cancer. Bariatric surgery is recognized to be the most effective weight loss intervention, but it is highly invasive and costly and can have serious side effects. Intragastric balloon (IGB) placement by endoscopy and hypocaloric diets are among a number of techniques that have been used in patients unsuitable for, or unwilling to undergo, obesity surgery. In this study, we compared the efficacy, safety, and cost-effectiveness of the hypocaloric OPTIFAST program (OPT) with endoscopic IGB placement for weight loss. METHODS: In this retrospective observational cohort propensity score-weighted comparison (performed May 2014 to December 2020), participants with a BMI of 30–55 kg/m<sup>2</sup>, aged 18–70 years, were randomized to OPT or IGB for 26 weeks, followed by a weight maintenance phase. Patients were matched according to age, gender, and BMI. The study outcomes were percentage excess body weight lost, total body weight lost (TBWL), and percentage TBWL (%TBWL). RESULTS: A total of 148 participants (75% of those randomized; 74 OPT, 74 IGB) made up the ITT population. Mean age was 44.1 ± 10.4 years, and the patients were predominantly female (77%). Baseline BMI was 44.1 ± 10.4 kg/m<sup>2</sup>. At 26 weeks, %TBWL in the OPT group was 19.6 ± 6.8% versus 11.9 ± 6.7% for IGB (p < 0.001). At 52 weeks, %TBWL for OPT was 18.2 ± 9.0% versus 12.0 ± 6.6% for IGB (p < 0.001). The OPT cohort also experienced significantly fewer adverse events compared with the IGB group. CONCLUSION: IGB placement and OPT induce clinically meaningful weight loss. However, OPT appears to induce clinically superior weight loss and has economic advantages through lower rates of complications and adverse events. S. Karger AG 2022-10-18 /pmc/articles/PMC9889727/ /pubmed/36257288 http://dx.doi.org/10.1159/000524895 Text en Copyright © 2022 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission.
spellingShingle Research Article
Oster, Miriam
Hein, Nathalena
Aksan, Aysegül
Krammer, Heiner
Theodoridou, Sophia
Stein, Jürgen
Efficacy and Safety of Intragastric Balloon Therapy Compared to a Multidisciplinary Weight Loss Program (OPTIFAST) in a Real-World Population: A Propensity Score Matching Analysis
title Efficacy and Safety of Intragastric Balloon Therapy Compared to a Multidisciplinary Weight Loss Program (OPTIFAST) in a Real-World Population: A Propensity Score Matching Analysis
title_full Efficacy and Safety of Intragastric Balloon Therapy Compared to a Multidisciplinary Weight Loss Program (OPTIFAST) in a Real-World Population: A Propensity Score Matching Analysis
title_fullStr Efficacy and Safety of Intragastric Balloon Therapy Compared to a Multidisciplinary Weight Loss Program (OPTIFAST) in a Real-World Population: A Propensity Score Matching Analysis
title_full_unstemmed Efficacy and Safety of Intragastric Balloon Therapy Compared to a Multidisciplinary Weight Loss Program (OPTIFAST) in a Real-World Population: A Propensity Score Matching Analysis
title_short Efficacy and Safety of Intragastric Balloon Therapy Compared to a Multidisciplinary Weight Loss Program (OPTIFAST) in a Real-World Population: A Propensity Score Matching Analysis
title_sort efficacy and safety of intragastric balloon therapy compared to a multidisciplinary weight loss program (optifast) in a real-world population: a propensity score matching analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889727/
https://www.ncbi.nlm.nih.gov/pubmed/36257288
http://dx.doi.org/10.1159/000524895
work_keys_str_mv AT ostermiriam efficacyandsafetyofintragastricballoontherapycomparedtoamultidisciplinaryweightlossprogramoptifastinarealworldpopulationapropensityscorematchinganalysis
AT heinnathalena efficacyandsafetyofintragastricballoontherapycomparedtoamultidisciplinaryweightlossprogramoptifastinarealworldpopulationapropensityscorematchinganalysis
AT aksanaysegul efficacyandsafetyofintragastricballoontherapycomparedtoamultidisciplinaryweightlossprogramoptifastinarealworldpopulationapropensityscorematchinganalysis
AT krammerheiner efficacyandsafetyofintragastricballoontherapycomparedtoamultidisciplinaryweightlossprogramoptifastinarealworldpopulationapropensityscorematchinganalysis
AT theodoridousophia efficacyandsafetyofintragastricballoontherapycomparedtoamultidisciplinaryweightlossprogramoptifastinarealworldpopulationapropensityscorematchinganalysis
AT steinjurgen efficacyandsafetyofintragastricballoontherapycomparedtoamultidisciplinaryweightlossprogramoptifastinarealworldpopulationapropensityscorematchinganalysis